A high α1-antitrypsin/interleukin-10 ratio predicts bacterial pneumonia in adults with community-acquired pneumonia: a prospective cohort study
Abstract Background Current microbiological tests fail to identify the causative microorganism in more than half of all pneumonia cases. We explored biomarkers that could be used for differentiating between bacterial and viral pneumonia in patients with community-acquired pneumonia (CAP). Methods In...
Main Authors: | Taiga Miyazaki, Kiyoyasu Fukushima, Kohji Hashiguchi, Shotaro Ide, Tsutomu Kobayashi, Toyomitsu Sawai, Kazuhiro Yatera, Yoshihisa Kohno, Yuichi Fukuda, Yoji Futsuki, Yuichi Matsubara, Hironobu Koga, Tomo Mihara, Eisuke Sasaki, Nobuyuki Ashizawa, Tatsuro Hirayama, Takahiro Takazono, Kazuko Yamamoto, Yoshifumi Imamura, Norihito Kaku, Kosuke Kosai, Yoshitomo Morinaga, Katsunori Yanagihara, Hiroshi Mukae |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-10-01
|
Series: | Pneumonia |
Subjects: | |
Online Access: | https://doi.org/10.1186/s41479-023-00118-4 |
Similar Items
-
Adjunctive corticosteroid therapy for inpatients with Mycoplasma pneumoniae pneumonia
by: Masato Tashiro, et al.
Published: (2017-12-01) -
Alpha-1 antitrypsin (AAT) reduces severity of Pseudomonas pneumonia in mice and inhibits epithelial barrier disruption and Pseudomonas invasion of respiratory epithelial cells
by: Gregory ePott, et al.
Published: (2013-06-01) -
Impact of the number of aspiration risk factors on mortality and recurrence in community-onset pneumonia
by: Noguchi S, et al.
Published: (2017-12-01) -
Role of biomarkers in community-acquired pneumonia management
by: Bahaeddin Onur, et al.
Published: (2024-07-01) -
Severe Nocardia pneumonia in an immunocompromised patient with alpha‐1 antitrypsin deficiency
by: Daryl E. C. Y. Chan, et al.
Published: (2020-11-01)